C12N 2500/95
Protein-free medium and culture conditions
C12N2500/95 (Protein-free medium and culture conditions) appears on 77 US grants and 119 published applications in this corpus.
Search patents in C12N- Granted patents
- 77
- Published applications
- 119
- Assignees
- 56
- Inventors
- 188
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 1 | 3 |
| 2005 | 0 | 7 |
| 2006 | 1 | 11 |
| 2007 | 1 | 9 |
| 2008 | 1 | 0 |
| 2009 | 3 | 6 |
| 2010 | 0 | 8 |
| 2011 | 3 | 8 |
| 2012 | 5 | 3 |
| 2013 | 6 | 8 |
| 2014 | 8 | 6 |
| 2015 | 2 | 9 |
| 2016 | 10 | 4 |
| 2017 | 5 | 9 |
| 2018 | 4 | 6 |
| 2019 | 8 | 3 |
| 2020 | 3 | 3 |
| 2021 | 4 | 1 |
| 2022 | 1 | 5 |
| 2023 | 1 | 3 |
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Low-serum medium composition for culturing Vero cells and use thereof24 Feb 2026US 12,559,728 B2LG Chem.Ltd.
- Methods for epicardial differentiation of human pluripotent stem cells28 Feb 2023US 11,591,569 B2Wisconsin Alumni Research Foundation
- ADAMTS13 protein cell culture supernatant22 Feb 2022US 11,254,921 B2Takeda Pharmaceutical Company Limited
- Cartilage and bone repair and regeneration using postpartum-derived cells7 Dec 2021US 11,191,789 B2DePuy Synthes Products, Inc.
- Method of differentiating umbilical cord tissue into a chondrogenic phenotype23 Nov 2021US 11,179,422 B2DePuy Synthes Products, Inc.
- Method for obtaining a neuromuscular organoid and use thereof3 Sep 2026US 2026/0258370 A1
- Methods of preparation of secretomes, and uses thereof23 Oct 2025US 2025/0325629 A1Immunis, Inc.
- Methods for producing cartilage and bones28 Aug 2025US 2025/0270507 A1Murdoch Childrens Research Institute
- Enhancement of extracellular vesicle production by lysosome inhibitor18 Jan 2024US 2024/0018472 A1ExoTop Theragnostics Inc.
- Enhancement of extracellular vesicle production by lysosome inhibitor18 Jan 2024US 2024/0018480 A1ExoTop Theragnostics Inc.
Most cited
By later US patents
- Serum-free, synthetic, completely chemically defined tissue culture media450US 4,657,866 A1987
- Treatment of retinitis pigmentosa with human umbilical cord cells175US 7,413,734 B2Ethicon, Inc. · 2008
- Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same84US 7,510,873 B2Ethicon, Inc. · 2009
- Soft tissue repair and regeneration using postpartum-derived cells76US 7,560,276 B2Ethicon, Inc. · 2009
- Protein-free culture medium which promotes hybridoma growth70US 5,045,468 ACell Enterprises, Inc. · 1991